Literature DB >> 15929174

Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer.

Bao-Can Wang1, Chang-Qing Guo, Chao Sun, Qiao-Ling Sun, Guo-Yong Liu, Ding-Guo Li.   

Abstract

AIM: To determine the correlation between methylation status of 5' CpG island of cyclooxygenase-2 (COX-2) gene and protein expression in gastric cancer tissues for distinguishing the molecular characters of gastric cancers.
METHODS: Methylation status of 5' CpG island of COX-2 gene was studied by PCR amplification after HpaII and Hha I restrictive enzyme digestion; COX-2 expression was evaluated by immunohistochemical method.
RESULTS: Hpa II and HhaI site were all methylated in 12 normal gastric mucosa tissues, whereas they were demethylated in 77.27% (34/44) and 84.09% (37/44) gastric cancer tissues, respectively. Expression of COX-2 was detected in 68.18% (30/44) gastric cancer tissues, but no expression was found in normal gastric mucosa tissues. In gastric cancer tissues, COX-2 expression was correlated significantly with HpaII site demethylation (29/30 vs 5/14, P<0.001 and HhaI site demethylation (28/30 vs 9/14, P<0.05).
CONCLUSION: The demethylation of 5' CpG island of gene is necessary for COX-2 expression in human gastric cancer. The expression status of COX-2 may provide theoretical basis for COX-2 targeting gastric cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929174      PMCID: PMC4316055          DOI: 10.3748/wjg.v11.i21.3240

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Long-range restriction site mapping of mammalian genomic DNA.

Authors:  W R Brown; A P Bird
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

2.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.

Authors:  M Toyota; N Ahuja; H Suzuki; F Itoh; M Ohe-Toyota; K Imai; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

3.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.

Authors:  S H Song; H S Jong; H H Choi; H Inoue; T Tanabe; N K Kim; Y J Bang
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

5.  Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA.

Authors:  H Sheng; J Shao; D A Dixon; C S Williams; S M Prescott; R N DuBois; R D Beauchamp
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

6.  Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region.

Authors:  D A Dixon; C D Kaplan; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

Review 7.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Karla Kerlikowske; Rajiv Verma; Patricia Buffler
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

8.  Expression of cyclooxygenase-1 and -2 in human breast cancer.

Authors:  Norio Yoshimura; Hajime Sano; Masahiko Okamoto; Kiyokazu Akioka; Hidetaka Ushigome; Yayoi Kadotani; Rikio Yoshimura; Shuji Nobori; Atsushi Higuchi; Yoshihiro Ohmori; Kenji Nakamura
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

9.  Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

Authors:  C J van der Woude; P L M Jansen; A T G M Tiebosch; A Beuving; M Homan; J H Kleibeuker; H Moshage
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

10.  Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.

Authors:  K Akre; A M Ekström; L B Signorello; L E Hansson; O Nyrén
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

View more
  4 in total

1.  Association of COX2 gene hypomethylation with intestinal type gastric cancer in samples of patients from northern Brazil.

Authors:  Cynthia Farias Vieira de Melo; Carolina Oliveira Gigek; Juarez Nóbrega da Silva; Marilia de Arruda Cardoso Smith; Rubistenia Miranda de Araújo; Rommel Rodríguez Burbano; Eleonidas Moura Lima
Journal:  Tumour Biol       Date:  2013-09-07

2.  Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".

Authors:  Da-zhi Sun; Jian-peng Jiao; Da-wei Ju; Min Ye; Xuan Zhang; Jing-yu Xu; Ye Lu; Jin He; Pin-kang Wei; Ming-hui Yang
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

3.  Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.

Authors:  Hui-juan Su; Yang Zhang; Lian Zhang; Jun-ling Ma; Ji-You Li; Kai-feng Pan; Wei-cheng You
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

4.  COX-2 gene expression and methylation profile in Sapajus apella as an experimental model for gastric adenocarcinoma.

Authors:  Danilo do Rosário Pinheiro; Maria Lucia Harada; Rommel Mario Rodriguez Burbano; Barbara do Nascimento Borges
Journal:  Genet Mol Biol       Date:  2018-05-14       Impact factor: 1.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.